| Patients n(%) | Controls n(%) |  | ||
---|---|---|---|---|---|
rs1799983 | Dominant model | GG | 99 (67.3%) | 60 (73.2%) | χ2 = 0.84 P = 0.36 OR (95% CI) = 0.76 (0.42–1.4) |
GTÂ +Â TT | 48 (32.7%) | 22 (26.8%) | |||
Recessive model | GG + GT | 142 (96.6%) | 80 (97.6%) | χ2 = 0.17 P = 0.69 OR (95% CI) = 0.71 (0.14–3.74) | |
TT | 5 (3.4%) | 2 (2.4%) | |||
Allele frequency | G | 242 (82.3%) | 140 (85.4%) | χ2 = 0.71 P = 0.40 OR (95% CI) = 0.80 (0.47–1.35) | |
T | 52 (17.7%) | 24 (14.6%) | |||
Intron 4 VNTR | Dominant model | bb | 144 (95.4%) | 75 (96.2%) | χ2 = 0.08 P = 0.78 OR (95% CI) = 0.82(0.21–3.3) |
ab + aa | 7 (4.6%) | 3 (3.8%) | |||
Recessive model | bb + ab | 83 (55%) | 50 (64.1%) | χ2 = 1.76 P = 0.18 OR (95% CI) = 0.68 (0.39–1.2) | |
aa | 68 (45%) | 28 (35.9%) | |||
Allele frequency | b | 227 (75.2%) | 125 (80.1%) | χ2 = 1.42 P = 0.23 OR (95% CI) = 1.33 (0.83–2.14) | |
a | 75 (24.8%) | 31 (19.9%) | |||
rs2070744 | Dominant model | TT | 72 (47.4%) | 54 (65.9%) | χ2 = 7.32 P = 0.007 OR (95% CI) = 2.14 (1.23–3.74) |
TCÂ +Â CC | 80 (52.6%) | 28 (34.1%) | |||
Recessive model | TT + TC | 142 (93.4%) | 78 (95.1%) | χ2 = 0.27 P = 0.60 OR (95% CI) = 0.73 (0.22–2.4) | |
CC | 10 (6.6%) | 4 (4.9%) | |||
Allele frequency | T | 214 (70.4%) | 131 (79.9%) | χ2 = 4.95 P = 0.03 OR (95% CI) = 1.84 (1.15–2.93) | |
C | 90 (29.6%) | 33 (20.1%) |